Taiwanese Pharmaceuticals & Biotech Most Popular Stocks

PharmaEssentia

Market Cap: NT$518.4b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Caliway Biopharmaceuticals

Market Cap: NT$155.2b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Pell Bio-Med Technology

Market Cap: NT$59.3b

A biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products.

Bora Pharmaceuticals

Market Cap: NT$56.0b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Lotus Pharmaceutical

Market Cap: NT$52.4b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Lin BioScience

Market Cap: NT$39.1b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

TLC BioSciences

Market Cap: NT$33.5b

Operates as a clinical-stage biotechnology company that develops and sells lipid-engineered medicines in Taiwan, the United States of America, Europe, and the Cayman Islands.

Center Laboratories

Market Cap: NT$29.6b

A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

Oneness Biotech

Market Cap: NT$27.5b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.

CHO Pharma

Market Cap: NT$27.4b

Engages in research and development of biotechnology in Taiwan.

HanchorBio

Market Cap: NT$21.0b

Operates as a biotechnology company that develops biologics for cancer patients.

Sunmax Biotechnology

Market Cap: NT$20.6b

A biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally.

TTY Biopharm

Market Cap: NT$19.4b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

TaiMed Biologics

Market Cap: NT$19.1b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

Lumosa Therapeutics

Market Cap: NT$18.0b

A clinical-stage pharmaceutical company, develops drugs for neurological and oncological diseases in Taiwan and the rest of Asia.

Handa Pharmaceuticals

Market Cap: NT$17.1b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

ScinoPharm Taiwan

Market Cap: NT$16.5b

A pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas.

Ever Supreme Bio Technology

Market Cap: NT$16.2b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Synmosa Biopharma

Market Cap: NT$15.9b

A specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally.

Medigen Vaccine Biologics

Market Cap: NT$15.2b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

EirGenix

Market Cap: NT$15.1b

Operates as a contract development and manufacturing company in Taiwan and internationally.

YungShin Global Holding

Market Cap: NT$14.5b

Through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics.

Pharmasaga

Market Cap: NT$13.6b

A drug discovery and development company, focuses on developing anti-diabetic drugs.

TCM Biotech International

Market Cap: NT$13.1b

A biotech company, engages in the research and development of drugs for liver diseases.

Foresee Pharmaceuticals

Market Cap: NT$13.1b

Operates as biopharmaceutical company in the United States, China, and Europe.

Polaris Group

Market Cap: NT$11.8b

Offers biotechnology, pharmaceutical testing, and contract development and manufacturing services.

Standard Chemical & Pharmaceutical

Market Cap: NT$11.4b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Gongwin Biopharm Holdings

Market Cap: NT$11.2b

A clinical-stage biopharmaceutical company, develops anticancer drugs in Hong Kong, China, and Singapore.

Tanvex BioPharma

Market Cap: NT$11.0b

A pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States.

ACRO Biomedical

Market Cap: NT$10.8b

Develops medical-grade regenerative biomaterials.

Elixiron Immunotherapeutics (Cayman)

Market Cap: NT$10.0b

Engages in the development of precision-targeted immunotherapy drugs in Shanghai, Taipei, the United States and Switzerland.

Locus Cell

Market Cap: NT$9.3b

Focuses on contract development and manufacturing organization (CDMO) services for cell therapy related products in Taiwan and the United States.

PharmaEngine

Market Cap: NT$9.2b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

AP Biosciences

Market Cap: NT$9.0b

Researches and develops protein and antibody drugs for unmet medical needs.

Alar Pharmaceuticals

Market Cap: NT$8.2b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Tripartite Therapeutics

Market Cap: NT$8.2b

Engages in the development of proprietary platform technologies for targeted delivery of therapeutics in Taiwan.